$120,000 of NOVAVAX INC lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to federal vaccine programs and vaccine regulatory frameworks"
You can find more data on corporate lobbying on Quiver Quantitative.
NVAX Hedge Fund Activity
We have seen 107 institutional investors add shares of NVAX stock to their portfolio, and 117 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TWO SIGMA INVESTMENTS, LP added 3,476,244 shares (+565.4%) to their portfolio in Q2 2026, for an estimated $32,746,218
- BANK OF AMERICA CORP /DE/ removed 3,220,978 shares (-48.5%) from their portfolio in Q2 2026, for an estimated $30,341,612
- UBS GROUP AG removed 2,608,042 shares (-58.2%) from their portfolio in Q2 2026, for an estimated $24,567,755
- MILLENNIUM MANAGEMENT LLC removed 2,084,382 shares (-54.1%) from their portfolio in Q2 2026, for an estimated $19,634,878
- SHAH CAPITAL MANAGEMENT removed 1,992,096 shares (-14.1%) from their portfolio in Q3 2026, for an estimated $21,534,557
- GOLDMAN SACHS GROUP INC added 1,598,310 shares (+113.4%) to their portfolio in Q2 2026, for an estimated $15,056,080
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,346,607 shares (+inf%) to their portfolio in Q2 2026, for an estimated $12,685,037
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
NVAX Price Targets
Multiple analysts have issued price targets for $NVAX recently. We have seen 2 analysts offer price targets for $NVAX in the last 6 months, with a median target of $14.0.
Here are some recent targets:
- Thomas Shrader from BTIG set a target price of $19.0 on 06/11/2026
- Chris LoBianco from TD Cowen set a target price of $9.0 on 05/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
